Published in BMC Public Health on March 20, 2008
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health (2012) 1.35
Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy (2009) 1.23
Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Subst Use Misuse (2011) 1.16
Epistemic fault lines in biomedical and social approaches to HIV prevention. J Int AIDS Soc (2011) 1.14
Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. J Infect Dis (2012) 1.08
Using positive deviance for determining successful weight-control practices. Qual Health Res (2010) 1.02
Correlates of staying safe behaviors among long-term injection drug users: psychometric evaluation of the staying safe questionnaire. AIDS Behav (2012) 0.92
Group sex events amongst non-gay drug users: an understudied risk environment. Int J Drug Policy (2010) 0.91
The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection. AIDS Educ Prev (2014) 0.91
Capability and clinical success. Ann Fam Med (2010) 0.90
Taking care of themselves: how long-term injection drug users remain HIV and Hepatitis C free. Sociol Health Illn (2015) 0.87
What does high and low have to do with it? Performance classification to identify health system factors associated with effective prevention of mother-to-child transmission of HIV delivery in Mozambique. J Int AIDS Soc (2014) 0.87
Surviving crack: a qualitative study of the strategies and tactics developed by Brazilian users to deal with the risks associated with the drug. BMC Public Health (2010) 0.86
Resilience among IDUs: planning strategies to help injection drug users to protect themselves and others from HIV/HCV infections. Subst Use Misuse (2012) 0.82
Learning from positively deviant wards to improve patient safety: an observational study protocol. BMJ Open (2015) 0.80
Homies with aspirations and positive peer network ties: associations with reduced frequent substance use among gang-affiliated Latino youth. J Urban Health (2015) 0.78
Seroadaptive Strategies of Gay & Bisexual Men (GBM) with the Highest Quartile Number of Sexual Partners in Vancouver, Canada. AIDS Behav (2016) 0.75
Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research. BMC Med Ethics (2009) 0.75
Gender differences in planning ability and hepatitis C virus among people who inject drugs. Addict Behav (2015) 0.75
Consistency of self-reported drug use events in a mixed methods study of people who inject drugs. Am J Drug Alcohol Abuse (2015) 0.75
In search of how people change. Applications to addictive behaviors. Am Psychol (1992) 28.48
Ordinary magic. Resilience processes in development. Am Psychol (2001) 8.75
Negative affectivity: the disposition to experience aversive emotional states. Psychol Bull (1984) 5.93
HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43
Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM). Health Educ Q (1990) 5.33
Resilience in the face of adversity. Protective factors and resistance to psychiatric disorder. Br J Psychiatry (1985) 5.19
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health (2001) 4.57
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis (2002) 3.83
Social action theory for a public health psychology. Am Psychol (1991) 3.20
Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology (2002) 2.99
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ (1998) 2.64
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology (2001) 2.54
The transtheoretical model of change and HIV prevention: a review. Health Educ Q (1994) 2.25
Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev (1999) 1.95
Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis (2002) 1.77
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr (2002) 1.68
Some data-driven reflections on priorities in AIDS network research. AIDS Behav (2007) 1.60
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis (2004) 1.54
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health (1997) 1.28
Harnessing the power of social networks to reduce HIV risk. Focus (2005) 1.23
How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18
Overcoming the odds. J Dev Behav Pediatr (1994) 1.12
Herpes simplex virus-2 and HIV among noninjecting drug users in New York city. Sex Transm Dis (2007) 1.09
Editorial: Can we learn from successful mothers? J Trop Pediatr Environ Child Health (1972) 1.07
The power of positive deviancy. An effort to reduce malnutrition in Vietnam offers an important lesson about managing change. Harv Bus Rev (2000) 1.04
Protective immunity against hepatitis C virus infection. Immunol Cell Biol (2006) 0.91
Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int J Epidemiol (2004) 0.86
Indications of immune protection from hepatitis C infection. J Urban Health (2004) 0.86
A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City. J Urban Health (2005) 0.84
A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination. Rev Panam Salud Publica (2005) 0.78
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health (2006) 4.85
The differential effects of face-to-face and computer interview modes. Am J Public Health (2002) 4.13
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS (2006) 3.55
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
Has United States drug policy failed? And how could we know? Subst Use Misuse (2012) 3.32
Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health (2003) 3.22
A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr (2002) 3.20
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis (2011) 3.13
Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction (2004) 2.97
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS (2005) 2.91
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr (2004) 2.90
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology (2004) 2.52
Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Educ Prev (2004) 2.31
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr (2002) 2.16
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy (2008) 2.15
Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev (2003) 2.03
Evaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. Ann Epidemiol (2010) 1.97
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr (2002) 1.97
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (2006) 1.88
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction (2007) 1.85
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83
Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr (2002) 1.78
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. Int J Drug Policy (2006) 1.74
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr (2005) 1.69
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr (2002) 1.68
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health (2013) 1.65
Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. Addiction (2013) 1.64
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach. Am J Public Health (2014) 1.62
Some data-driven reflections on priorities in AIDS network research. AIDS Behav (2007) 1.60
Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction (2012) 1.55
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.50
Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. Int J STD AIDS (2002) 1.50
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health (2009) 1.49
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Incarceration, sex with an STI- or HIV-infected partner, and infection with an STI or HIV in Bushwick, Brooklyn, NY: a social network perspective. Am J Public Health (2011) 1.46
Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend (2008) 1.41
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend (2012) 1.41
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction (2007) 1.41
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend (2008) 1.41
A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat (2002) 1.40
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS (2005) 1.40
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
The HCV Synthesis Project: scope, methodology, and preliminary results. BMC Med Res Methodol (2008) 1.34
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health (2011) 1.32
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.31
Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women. Am J Public Health (2010) 1.31
Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam. J Acquir Immune Defic Syndr (2005) 1.31
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction (2003) 1.30
Group sex events and HIV/STI risk in an urban network. J Acquir Immune Defic Syndr (2008) 1.28
An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav (2013) 1.27
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26
Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med (2007) 1.24
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23
Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors. Health Place (2011) 1.23
Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy (2009) 1.23
Harnessing the power of social networks to reduce HIV risk. Focus (2005) 1.23
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend (2010) 1.21
Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. J Urban Health (2010) 1.21
Reconsidering the internet as an HIV/STD risk for men who have sex with men. AIDS Behav (2010) 1.21
Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.21
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav (2013) 1.20